Bio-Rad Laboratories, Inc. Class A Common Stock · Depreciation & Amortization

Latest reported$127.60Mperiod endingJun 30, 2026

BIO Depreciation & Amortization ($7.90M → $127.60M)

Annual Depreciation & Amortization

High-resolution chart · PNG

BIO depreciation & amortization history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Depreciation & Amortization — Annual fiscal periods (USD)
Period ending	Depreciation & Amortization (USD)
Dec 31, 2025	165,400,000
Dec 31, 2024	151,600,000
Dec 31, 2023	145,900,000
Dec 31, 2022	137,300,000
Dec 31, 2021	137,600,000
Dec 31, 2020	138,600,000
Dec 31, 2019	134,200,000
Dec 31, 2018	138,100,000
Dec 31, 2017	148,700,000
Dec 31, 2016	142,900,000
Dec 31, 2015	131,800,000
Dec 31, 2014	149,900,000
Dec 31, 2013	147,200,000
Dec 31, 2012	130,400,000
Dec 31, 2011	121,000,000
Dec 31, 2010	108,900,000
Dec 31, 2009	101,700,000
Dec 31, 2008	97,100,000
Dec 31, 2007	67,300,000
Dec 31, 2006	55,400,000
Dec 31, 2005	61,000,000
Dec 31, 2004	55,500,000
Dec 31, 2003	42,000,000
Dec 31, 2002	38,000,000
Dec 31, 2001	41,300,000
Dec 31, 2000	43,309,000
Dec 31, 1999	27,495,000
Dec 31, 1998	20,975,000
Dec 31, 1997	19,500,000
Dec 31, 1996	17,900,000
Dec 31, 1995	16,700,000
Dec 31, 1994	16,800,000
Dec 31, 1993	16,600,000
Dec 31, 1992	13,900,000
Dec 31, 1991	12,100,000
Dec 31, 1990	10,300,000
Dec 31, 1989	7,900,000